Skip to Main Content

Paper Details

Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis.
Diabetes Obes Metab
8
2022
Author NameAffiliation
Kenneth W MahaffeyStanford Center for Clinical Research, Stanford University School of Medicine
Christopher P CannonBrigham & Women's Hospital and Baim Institute for Clinical Research
  • 1 - 2

Datasets

Release 1.2